Last Updated on November 4, 2022
Introduction
- A non-dihydropyridine / rate-limiting calcium channel blocker
- Negative inotropic effect
Indications
- Supraventricular tachycardia
- Hypertension
Doses
Hypertension
- T Verapamil 80 mg TDS – 160 mg TDS
Supraventricular tachycardia
- IV Verapamil 2.5 mg – 5 mg slow bolus
Contraindications
- Ventricular tachycardia
- Avoided in atrial fibrillation with underlying heart failure, as it has negative inotropic effect